Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02568878 · ClinicalTrials.gov registry record · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
A Phase 3 study of Depression and Anxiety, sponsored by Montana State University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT02568878: Recruiting Phase 3 study of Depression and Anxiety, sponsored by Montana State University.
NCT02568878 is a Phase 3 study of Depression and Anxiety that is actively recruiting participants, run by Montana State University. The registered enrollment target is 29 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02568878, a Phase 3 study of Depression and Anxiety, is actively recruiting participants, sponsored by Montana State University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
* Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression
Conditions Studied
Interventions
- DRUG Creatine monohydrate
Study Locations (1)
Montana
- Montana State University College of Nursing (Missoula campus) - Missoula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-05 |
| Phase | Phase 3 |
What NCT02568878 shows while recruiting
NCT02568878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Creatine monohydrate is the first listed.
NCT02568878 reports a single indexed study location in Montana.
Frequently Asked Questions
What is clinical trial NCT02568878 about?
NCT02568878 is a clinical study titled "Creatine for Depressed Male and Female Methamphetamine Users". * Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression
What is the current status of trial NCT02568878?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 29 participants. The study started on 2015-11. Estimated completion is 2017-05.
What conditions does trial NCT02568878 study?
This clinical trial studies the following conditions: Depression, Anxiety, Methamphetamine-dependence.
What interventions are being tested in trial NCT02568878?
The interventions under investigation include: Creatine monohydrate (DRUG).
Who is sponsoring clinical trial NCT02568878?
This trial is sponsored by Montana State University, which has 36 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02568878 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02568878's enrollment target sits among peer trials
29 576th of 679 higher than 99 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
RECRUITING · Phase 3
-
E-Mindfulness Approaches for Living After Breast Cancer
RECRUITING · Phase 3
-
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
- NCT03531450 · 29 participants · NA
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia